AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 11%
#525 out of 5181 analysts
Average Return
+11.75%
Win Rate
51%75 out of 146
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | +323.81% | $16.42 | $69.59 | 2025-08-07 - 2026-01-22 | Buy |
Arrowhead Pharmaceuticals IncARWR | +268.40% | $18.89 | $69.59 | 2025-02-10 - 2026-01-22 | Buy |
Uniqure NvQURE | +263.97% | $7.16 | $26.06 | 2024-11-05 - 2025-11-05 | Buy |
Ionis Pharmaceuticals IncIONS | +150.20% | $32.69 | $81.79 | 2025-02-19 - 2026-01-22 | Buy |
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-15 - 2025-01-15 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 4 | Buy | $250.00 | +9.34% | Maintains | 3 days ago |
Alnylam Pharmaceuticals IncALNY | 28 | Buy | $465.00 | +25.68% | Maintains | 3 days ago |
Argenx SeARGX | 3 | Buy | $925.00 | +11.85% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 11 | Buy | $95.00 | +16.15% | Maintains | a month ago |
Arrowhead Pharmaceuticals IncARWR | 11 | Buy | $80.00 | +14.96% | Maintains | a month ago |
Wave Life Sciences LtdWVE | 6 | Buy | $27.00 | +95.37% | Upgrades | a month ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $10.00 | -9.50% | Maintains | 2 months ago |
Moderna IncMRNA | 18 | Hold | $25.00 | -51.80% | Maintains | 2 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Hold | $28.00 | -2.30% | Downgrades | 2 months ago |
Korro Bio IncKRRO | 8 | Hold | $8.00 | -23.88% | Downgrades | 2 months ago |
Crispr Therapeutics AgCRSP | 14 | Hold | $50.00 | -17.78% | Maintains | 2 months ago |
Regenxbio IncRGNX | 10 | Buy | $19.00 | +18.90% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 7 | Hold | $9.00 | -43.40% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 4 | Buy | $30.00 | +65.93% | Maintains | 3 months ago |
Uniqure NvQURE | 7 | Buy | $45.00 | +98.33% | Maintains | 3 months ago |
Avidity Biosciences IncRNA | 3 | Hold | $72.00 | -1.02% | Downgrades | 3 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | -8.26% | Maintains | 8 months ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +481.40% | Reiterates | 8 months ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -18.18% | Maintains | 9 months ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +160.42% | Maintains | 10 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +401.25% | Reiterates | 10 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +52.88% | Initiates Coverage On | 10 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +56.44% | Maintains | 10 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +34.77% | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +332.63% | Maintains | a year ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | -24.11% | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +22.42% | Reiterates | a year ago |
Slb LimitedSLB | 1 | Buy | $57.00 | N/A | Reiterates | a year ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | N/A | Maintains | a year ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | N/A | Reiterates | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | N/A | Reiterates | a year ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | a year ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.